File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.4049/jimmunol.1500222
- Scopus: eid_2-s2.0-84928473008
- PMID: 25888699
- WOS: WOS:000353727400001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Nomenclature of Toso, Fas apoptosis inhibitory molecule 3, and IgM FcR
Title | Nomenclature of Toso, Fas apoptosis inhibitory molecule 3, and IgM FcR |
---|---|
Authors | |
Issue Date | 2015 |
Citation | Journal of Immunology, 2015, v. 194, n. 9, p. 4055-4057 How to Cite? |
Abstract | Copyright © 2015 by The American Association of Immunologists, Inc. Hiromi Kubagawa and John E. Coligan coordinated an online meeting to define an appropriate nomenclature for the cell surface glycoprotein presently designated by different names: Toso, Fas apoptosis inhibitory molecule 3 (FAIM3), and IgM FcR (FcμR). FAIM3 and Faim3 are the currently approved symbols for the human and mouse genes, respectively, in the National Center for Biotechnology Information, Ensembl, and other databases. However, recent functional results reported by several groups of investigators strongly support a recommendation for renaming FAIM3/Faim3 as FCMR/Fcmr, a name better reflecting its physiological function as the FcR for IgM. Participants included 12 investigators involved in studying Toso/FAIM3(Faim3)/FμR, representatives from the Human Genome Nomenclature Committee (Ruth Seal) and the Mouse Genome Nomenclature Committee (Monica McAndrews), and an observer from the IgM research field (Michael Carroll). In this article, we provide a brief background of the key research on the Toso/FAIM3(Faim3)/FcμR proteins, focusing on the ligand specificity and functional activity, followed by a brief summary of discussion about adopting a single name for this molecule and its gene and a resulting recommendation for genome nomenclature committees. |
Persistent Identifier | http://hdl.handle.net/10722/292877 |
ISSN | 2023 Impact Factor: 3.6 2023 SCImago Journal Rankings: 1.558 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kubagawa, Hiromi | - |
dc.contributor.author | Carroll, Michael C. | - |
dc.contributor.author | Jacob, Chaim O. | - |
dc.contributor.author | Lang, Karl S. | - |
dc.contributor.author | Lee, Kyeong Hee | - |
dc.contributor.author | Mak, Tak | - |
dc.contributor.author | McAndrews, Monica | - |
dc.contributor.author | Morse, Herbert C. | - |
dc.contributor.author | Nolan, Garry P. | - |
dc.contributor.author | Ohno, Hiroshi | - |
dc.contributor.author | Richter, Günther H. | - |
dc.contributor.author | Seal, Ruth | - |
dc.contributor.author | Wang, Ji Yang | - |
dc.contributor.author | Wiestner, Adrian | - |
dc.contributor.author | Coligan, John E. | - |
dc.date.accessioned | 2020-11-17T14:57:24Z | - |
dc.date.available | 2020-11-17T14:57:24Z | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | Journal of Immunology, 2015, v. 194, n. 9, p. 4055-4057 | - |
dc.identifier.issn | 0022-1767 | - |
dc.identifier.uri | http://hdl.handle.net/10722/292877 | - |
dc.description.abstract | Copyright © 2015 by The American Association of Immunologists, Inc. Hiromi Kubagawa and John E. Coligan coordinated an online meeting to define an appropriate nomenclature for the cell surface glycoprotein presently designated by different names: Toso, Fas apoptosis inhibitory molecule 3 (FAIM3), and IgM FcR (FcμR). FAIM3 and Faim3 are the currently approved symbols for the human and mouse genes, respectively, in the National Center for Biotechnology Information, Ensembl, and other databases. However, recent functional results reported by several groups of investigators strongly support a recommendation for renaming FAIM3/Faim3 as FCMR/Fcmr, a name better reflecting its physiological function as the FcR for IgM. Participants included 12 investigators involved in studying Toso/FAIM3(Faim3)/FμR, representatives from the Human Genome Nomenclature Committee (Ruth Seal) and the Mouse Genome Nomenclature Committee (Monica McAndrews), and an observer from the IgM research field (Michael Carroll). In this article, we provide a brief background of the key research on the Toso/FAIM3(Faim3)/FcμR proteins, focusing on the ligand specificity and functional activity, followed by a brief summary of discussion about adopting a single name for this molecule and its gene and a resulting recommendation for genome nomenclature committees. | - |
dc.language | eng | - |
dc.relation.ispartof | Journal of Immunology | - |
dc.title | Nomenclature of Toso, Fas apoptosis inhibitory molecule 3, and IgM FcR | - |
dc.type | Article | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.4049/jimmunol.1500222 | - |
dc.identifier.pmid | 25888699 | - |
dc.identifier.scopus | eid_2-s2.0-84928473008 | - |
dc.identifier.volume | 194 | - |
dc.identifier.issue | 9 | - |
dc.identifier.spage | 4055 | - |
dc.identifier.epage | 4057 | - |
dc.identifier.eissn | 1550-6606 | - |
dc.identifier.isi | WOS:000353727400001 | - |
dc.identifier.issnl | 0022-1767 | - |